Ser Archer (Talk | contribs) |
Ser Archer (Talk | contribs) |
||
Line 53: | Line 53: | ||
<div class="block" style="background-color:#F0DAD2;top:0;"> | <div class="block" style="background-color:#F0DAD2;top:0;"> | ||
<div class="content-text" id="content-text"> | <div class="content-text" id="content-text"> | ||
− | <h3> | + | <h3>Cancer Gene Therapy</h3> |
Gene therapy is the transfer of defined genetic material to specific target cells of a patient for the ultimate purpose of preventing or altering a particular disease state. Since cancer is mediated by somatic aberration in the host genome, it is not difficult to explain the enthusiasm about gene therapy among cancer researchers. It is anticipated that gene therapy will play an important role in future cancer therapy as part of a multimodality treatment, in combination with, or following other forms of cancer therapy. In this year’s iGEM competition, we focus on hepatocellular carcinoma (HCC), which is the sixth most common cancer and ranks third in cancer-related deaths. Although we have treatments such as transplantation, surgical resection and local ablation for early HCC, problems lie in the lack of donor, postoperative recurrence, etc. | Gene therapy is the transfer of defined genetic material to specific target cells of a patient for the ultimate purpose of preventing or altering a particular disease state. Since cancer is mediated by somatic aberration in the host genome, it is not difficult to explain the enthusiasm about gene therapy among cancer researchers. It is anticipated that gene therapy will play an important role in future cancer therapy as part of a multimodality treatment, in combination with, or following other forms of cancer therapy. In this year’s iGEM competition, we focus on hepatocellular carcinoma (HCC), which is the sixth most common cancer and ranks third in cancer-related deaths. Although we have treatments such as transplantation, surgical resection and local ablation for early HCC, problems lie in the lack of donor, postoperative recurrence, etc. | ||
Revision as of 13:08, 6 June 2018